Skip to content

Clinical trials

Phase 1 Gastrointestinal Stromal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 1 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20031
20041
20052
20062
20072
20081
20111
20121
20131
20141
20153
20171
20191
20201
20212
20222
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting3
Terminated3
Active, not recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center3
Novartis Pharmaceuticals3
Blueprint Medicines Corporation2
Dana-Farber Cancer Institute2
Deciphera Pharmaceuticals, LLC2
Astellas Pharma Inc1
Case Comprehensive Cancer Center1
DNAtrix, Inc.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors32
Stomach Neoplasms9
Appendiceal Neoplasms7
Carcinoma, Hepatocellular7
Carcinoma, Non-Small-Cell Lung7
Gallbladder Neoplasms7
Pancreatic Neoplasms7
Sarcoma7
Bile Duct Neoplasms6
Colonic Neoplasms6

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.